An interventional study of Target Heartrate Aerobic Exercise in Concussion, Brain, sponsored by State University of New York at Buffalo. Completed at 1 site in United States. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 420 studies in Brain Concussion with a site in United States — 102 open to participants now, 123 under way, 5 of them phase 3. Brain Concussion · United States.
Among the 420 studies in Brain Concussion with a site in United States, this one is the 288th largest by enrollment of the 323 interventional ones that give a count, is one of 28 that started in 2024, is one of 265 with no phase, and was the 347th registered.
641 studies on the registry are indexed under Brain Concussion; 167 are open to participants now.
Browse Brain Concussion studies →102 of the 420 studies in Brain Concussion with a site in United States are open now. Recruiting first, the newest first:
Johns Hopkins University · Sites in United States
Ages 18–55
HealthPartners Institute · Sites in United States
Ages 18–65
University of Michigan · Sites in United States
Ages 18+
Perception Dynamics Institute · Sites in United States
Ages 18–60
University of Colorado, Denver · Sites in United States
Ages 18+ · Men only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 114 Brain Concussion studies recruiting now, 34 (30%) set no upper age limit and 73 (64%) stop at 75 or younger; 24 take children under 18; 38 take healthy volunteers.
This study: 18 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
420 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 21 · Phase 2 29 · Phase 3 9 · Phase 4 5
First in 1998; this study’s year is marked. 28 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 11 is below the median of 63 across 449 interventional studies indexed under Brain Concussion.
Median enrollment 60 across the 323 interventional studies, 147 across the 96 observational. Of the 259 that completed or were terminated, 68 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
59 of 420 have an industry lead sponsor. The 10 most frequent:
State University of New York at Buffalo is the lead sponsor of 294 studies on the registry; 63 are open to participants now.
Of its 19 completed or terminated interventional studies of FDA-regulated products, 15 (79%) have results posted.
State University of New York at Buffalo has 7 studies filed under Brain Concussion — fewer than ten, so there is no comparison to draw.
50 of the studies in Brain Concussion with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04867317Phase 3VA Office of Research and DevelopmentGrowth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) | 2027-02-28 |
| NCT05320822University of North Carolina, Chapel HillA Pragmatic Rehabilitation Intervention: The Active Rehab Study | 2026-11-28 |
| NCT06109909VA Office of Research and DevelopmentPilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury | 2026-11-30 |
| NCT02670161Endeavor HealthQuality Improvement and Practice Based Research in Neurology Using the EMR | 2026-12 |
| NCT04708613David Okonkwo, MD, PhDUniversity of Pittsburgh Brain Health Initiative | 2026-12 |
Add all 50 to your calendar (.ics) → With an account.
Among the 420 studies in Brain Concussion with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
There is a lot of research on how to treat people with sport-related concussion. There has not been a lot of research on the treatment of injured workers with concussion. An exercise program has been developed for people with sport-related concussion. It is suspected that this program may be helpful for injured workers with concussion too. This study will test the effect of this exercise in injured workers with concussion.
Participants who are diagnosed with a concussion and agree to participant in the study will complete a demographics form and other relevant questionnaires. They will then perform a graded exertion test (the Buffalo Concussion Treadmill Test [BCTT]) at the clinic, this takes approximately 15 minutes. Participants will then be prescribed the individualized THRAE based on the results from the BCTT and will be sent home with a commercial heart rate monitor. Participants will perform exercises at home on their free time 4-5 days per week. Participants will return to the clinic weekly to be re-examined by the study physician and obtain a new heart rate prescription for the first six weeks until clinical recovery or the intervention period ends (6-weeks).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will be asked to complete the Buffalo Concussion Treadmill Test (BCTT), a safe graded exercise test that is used to identify concussion-related exertion intolerance. Participants will wear a heart rate (HR) monitor for the collection of continuous HR data. The test is stopped when a participant's symptoms increase subjectively by an intensity of 3 points or more from the pre-exercise value on a scale from 0-10, or they report being physically exhausted. Their HR at the time of test termination constitutes the HR threshold (HRt). An individualized THRAE program will be prescribed based on 80% of the HRt on the BCTT. Participants will be given a Polar HR monitor to wear while performing their THRAE prescription, which will be performed at home for 20 minutes, 4-5 days per week, for 6 weeks or until medically cleared from their concussion.
Behavioral: Target Heartrate Aerobic Exercise
Exercise program
Subjective Adherence to Target Heartrate Aerobic Exercise (THRAE) Program as Measured by Counting the Number and Duration of Exercise Sessions Completed.
Subjective Adherence to Target Heartrate Aerobic Exercise (THRAE) program as measured by a subjective report at each weekly meeting with the study's research assistant of exercise sessions performed. Participants were considered adherent if they complete 66% or more of their prescribed exercise sessions
Time frame: Up to 6 weeks
Objective Adherence to Target Heartrate Aerobic Exercise (THRAE)
Objective Adherence to Target Heartrate Aerobic Exercise (THRAE) program as measured by counting exercise sessions completed across participants using Polar app. Adherence was calculated by counting the number of exercise sessions logged within the system for all participants and dividing that value by the number days all subjects were eligible to exercise during their time in the study.
Time frame: Up to 6 weeks.
Change in Post-concussive Symptom Burden as Measured by the Post-Concussion Symptom Scale
The Post-Concussion Symptom Scale (PCSS) is a validated 22-item self-report symptom questionnaire. Scores range from 0-132 with greater scores indicating increased symptom burden.
Time frame: Baseline and final visit (6 weeks) or the visit the participant was deemed recovered, whichever occurred first.
Change in Patient Health Questionnaire-9 (PHQ-9)
The Patient Health Questionnaire-9 (PHQ-9) is used for rating the severity of depression among participants. Scores range from 0-27. Higher scores indicate increased severity of depression. To calculate change in Patient Health Questionnaire-9 (PHQ-9) scores, the mean final PHQ-9 score for all participants was subtracted from the mean initial score for all participants.
Time frame: Baseline, up to week 6
Change in Generalized Anxiety Disorder-7 (GAD-7)
The Generalized Anxiety Disorder-7 (GAD-7) is used to measure the severity of anxiety among participants. Scores range from 0-21. Higher scores indicate increased severity of anxiety.
Time frame: Baseline, up to week 6
Number of Participants With Positive Primary Care Post Traumatic Stress Disorder (PTSD) Screen for DSM-5 (PC-PTSD-5)
This is a brief screening measure designed to identify individuals with probable post-traumatic stress disorder (PTSD). The measure begins with a trauma-exposure screening item; if no trauma exposure is endorsed, the score is 0. If trauma exposure is endorsed, 5 yes/no symptom items are completed. The total score is calculated by adding the number of "yes" responses yielding a range from 0 to 5. Lower scores indicate lower likelihood of PTSD; higher scores indicate greater likelihood of PTSD. Greater than 2 "yes" responses was considered a positive screen.
Time frame: Baseline
Change in Patient-Reported Outcomes Measurement Information System Global Health-10 (PROMIS-10)
The PROMIS Global Health-10 is a 10-item patient-reported measure of general health-related quality of life, including physical, mental, and social health. Raw scores are converted to a standardized T-score. T-scores have a mean of 50 and standard deviation of 10 in the reference population. Higher scores represent a better outcome, indicating better global physical or mental health; lower scores represent a worse outcome. Change in PROMIS-10 was calculated by subtracting the average score for all participants at Visit 1 from the average score for all participants at the final visit.
Time frame: Baseline, up to week 6
Work Climate Questionnaire - 6-Item Version
The Work Climate Questionnaire - 6-Item Version is used for assessing participants' perceptions regarding the degree of autonomy supportiveness of their work managers or employers. Scores range of 6-42. Higher scores indicate a greater degree of perceived autonomy supportiveness.
Time frame: Baseline
Change in Basic Psychological Needs Satisfaction and Frustration Scale (BPNSFS)
This is a self-report measure assessing satisfaction and frustration of three basic psychological needs: autonomy, competence, and relatedness. Twenty-four items are rated from 1 to 5. Possible scores range from 24-120. Higher scores indicate greater psychological need satisfaction and less frustration. Change in this measure was calculated by subtracting the average score for all participants obtained at the final visit from the average score for all participants obtained at the initial study visit.
Time frame: Baseline, up to week 6
Rate of Adverse Events as Assessed by Questioning the Participant
At each weekly follow-up meeting participants will be asked about any adverse events including injuries or other negative events.
Time frame: Throughout the duration of the study, up to 6 weeks.
Prospective participants will came to the UBMD Concussion Clinic to be seen for their concussion injury. The treating physician, who was also a member of the research team, performed a clinician examination in private exam rooms and diagnosed patients with a concussion or not. If diagnosed with a concussion and eligible to participate, the study physician informed them about the study and asked a research assistant to come to the exam room and explain the study and obtain consent (if interested)
| Milestone | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Started | 11 |
| Completed | 10 |
| Not completed | 1 |
| Withdrew: Lost to follow-up | 1 |
Subjective Adherence to Target Heartrate Aerobic Exercise (THRAE) program as measured by a subjective report at each weekly meeting with the study's research assistant of exercise sessions performed. Participants were considered adherent if they complete 66% or more of their prescribed exercise sessions
| Participants | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Subjective Adherence to Target Heartrate Aerobic Exercise (THRAE) Program as Measured by Counting the Number and Duration of Exercise Sessions Completed. | 8 |
Objective Adherence to Target Heartrate Aerobic Exercise (THRAE) program as measured by counting exercise sessions completed across participants using Polar app. Adherence was calculated by counting the number of exercise sessions logged within the system for all participants and dividing that value by the number days all subjects were eligible to exercise during their time in the study.
| percentage of sessions completed | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Objective Adherence to Target Heartrate Aerobic Exercise (THRAE) | 17.4 (2.43 to 60.69) |
The Post-Concussion Symptom Scale (PCSS) is a validated 22-item self-report symptom questionnaire. Scores range from 0-132 with greater scores indicating increased symptom burden.
| score on a scale | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Change in Post-concussive Symptom Burden as Measured by the Post-Concussion Symptom Scale | 35.25 ± 29.41 |
The Patient Health Questionnaire-9 (PHQ-9) is used for rating the severity of depression among participants. Scores range from 0-27. Higher scores indicate increased severity of depression. To calculate change in Patient Health Questionnaire-9 (PHQ-9) scores, the mean final PHQ-9 score for all participants was subtracted from the mean initial score for all participants.
| score on a scale | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Baseline | 10.8 ± 6.5 |
| Final | 6.6 ± 5.7 |
The Generalized Anxiety Disorder-7 (GAD-7) is used to measure the severity of anxiety among participants. Scores range from 0-21. Higher scores indicate increased severity of anxiety.
| score on a scale | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Baseline | 7.5 ± 5.8 |
| Final | 5.3 ± 6.1 |
This is a brief screening measure designed to identify individuals with probable post-traumatic stress disorder (PTSD). The measure begins with a trauma-exposure screening item; if no trauma exposure is endorsed, the score is 0. If trauma exposure is endorsed, 5 yes/no symptom items are completed. The total score is calculated by adding the number of "yes" responses yielding a range from 0 to 5. Lower scores indicate lower likelihood of PTSD; higher scores indicate greater likelihood of PTSD. Greater than 2 "yes" responses was considered a positive screen.
| Participants | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Number of Participants With Positive Primary Care Post Traumatic Stress Disorder (PTSD) Screen for DSM-5 (PC-PTSD-5) | 4 |
The PROMIS Global Health-10 is a 10-item patient-reported measure of general health-related quality of life, including physical, mental, and social health. Raw scores are converted to a standardized T-score. T-scores have a mean of 50 and standard deviation of 10 in the reference population. Higher scores represent a better outcome, indicating better global physical or mental health; lower scores represent a worse outcome. Change in PROMIS-10 was calculated by subtracting the average score for all participants at Visit 1 from the average score for all participants at the final visit.
| score on a scale | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Baseline | 33.9 ± 7.1 |
| Final | 32.6 ± 7.7 |
The Work Climate Questionnaire - 6-Item Version is used for assessing participants' perceptions regarding the degree of autonomy supportiveness of their work managers or employers. Scores range of 6-42. Higher scores indicate a greater degree of perceived autonomy supportiveness.
| score on a scale | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Work Climate Questionnaire - 6-Item Version | 25 ± 8.47 |
This is a self-report measure assessing satisfaction and frustration of three basic psychological needs: autonomy, competence, and relatedness. Twenty-four items are rated from 1 to 5. Possible scores range from 24-120. Higher scores indicate greater psychological need satisfaction and less frustration. Change in this measure was calculated by subtracting the average score for all participants obtained at the final visit from the average score for all participants obtained at the initial study visit.
| score on a scale | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Baseline | 72.5 ± 6.7 |
| Final | 70 ± 4.6 |
At each weekly follow-up meeting participants will be asked about any adverse events including injuries or other negative events.
| Participants | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Rate of Adverse Events as Assessed by Questioning the Participant | 0 |
Collected over Throughout the duration of the study, up to 6 weeks.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Target Heartrate Aerobic Exercise (THRAE) | 0/10 (0%) | 0/10 (0%) | 0/10 (0%) |
| Age, Continuous(years) | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Mean | 29.3 ± 6.33 |
| Sex: Female, Male(Participants) | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Female | 6 |
| Male | 4 |
| Race and Ethnicity Not Collected(Participants) | Target Heartrate Aerobic Exercise (THRAE) |
|---|
| Region of Enrollment(participants) | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| United States | 10 |
| Post Concussion Symptom Scale(scores on a scale) | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Mean | 60.30 ± 39.26 |
| Patient-Reported Outcomes Measurement Information System Global Health-10(T-score) | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Mean | 33.9 ± 7.13 |
| Basic Psychological Needs Satisfaction and Frustration Scale(units on a scale) | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Mean | 49.06 ± 5.02 |
| Patient Health Questionnaire 9(units on a scale) | Target Heartrate Aerobic Exercise (THRAE) |
|---|---|
| Mean | 10.8 ± 6.53 |
3 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Jul 2024 to primary completion in Apr 2025, 9 months.
Results were first posted in Oct 2026, 1 year 5 months after primary completion.
Of 249 non-industry interventional studies with no phase under Brain Concussion, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 47. This study's 9 months is below that.
Counting every sponsor, half of 265 studies reached it within 28 months; a quarter within 19 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
State University of New York at Buffalo →